(Q48562979)

12 February 2018

title

Biochemical detection of left-ventricular systolic dysfunction (English)

1 reference

12 February 2018

1 reference

T A McDonagh

1

1 reference

12 February 2018

S D Robb

2

1 reference

12 February 2018

D R Murdoch

3

1 reference

12 February 2018

J J Morton

4

1 reference

12 February 2018

I Ford

5

1 reference

12 February 2018

C E Morrison

6

1 reference

12 February 2018

H Tunstall-Pedoe

7

1 reference

12 February 2018

J J McMurray

8

1 reference

12 February 2018

H J Dargie

9

1 reference

12 February 2018

language of work or name

English

0 references

publication date

1 January 1998

1 reference

12 February 2018

published in

The Lancet

1 reference

12 February 2018

volume

351

1 reference

12 February 2018

issue

9095

1 reference

12 February 2018

page(s)

9-13

1 reference

12 February 2018

The Natural History of Congestive Heart Failure: The Framingham Study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903034-1

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903034-1

7 January 2021

Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903034-1

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903034-1

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903034-1

7 January 2021

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903034-1

7 January 2021

Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903034-1

7 January 2021

Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903034-1

7 January 2021

Natriuretic peptide system in human heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903034-1

7 January 2021

Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903034-1

7 January 2021

Left ventricular volume from paired biplane two-dimensional echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903034-1

7 January 2021

Dietary sodium loading increases plasma brain natriuretic peptide levels in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903034-1

7 January 2021

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903034-1

7 January 2021

Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903034-1

7 January 2021

Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903034-1

7 January 2021

Plasma brain natriuretic peptide in assessment of acute dyspnoea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903034-1

7 January 2021

Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903034-1

7 January 2021

Predictive properties of serum-prostate-specific antigen testing in a community-based setting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903034-1

7 January 2021

10.1016/S0140-6736(97)03034-1

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018